Biocept Receives $19,000,000 New Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    5810 Nancy Ridge Drive San Diego, CA 92121
  • Company Description
    Biocept (NASDAQ: BIOC) is a leader in genetic testing. The company’s proprietary CEE Cell Enrichment and Extraction technology is designed to isolate and extract rare cells for highly accurate genetic analysis. CEE will be used exclusively in Biocept Laboratories’ first product, preCEEd prenatal diagnostic.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

Trending on Xconomy